{"id":"https://openalex.org/W2051297618","doi":"https://doi.org/10.1002/(sici)1097-0142(19990301)85:5<1091::aid-cncr12>3.0.co;2-a","title":"A prospective, randomized phase III trial comparing combination chemotherapy with cyclophosphamide, doxorubicin, and 5-fluorouracil with vinorelbine plus doxorubicin in the treatment of advanced breast carcinoma","display_name":"A prospective, randomized phase III trial comparing combination chemotherapy with cyclophosphamide, doxorubicin, and 5-fluorouracil with vinorelbine plus doxorubicin in the treatment of advanced breast carcinoma","alternate_titles":[],"publication_year":1999,"publication_date":"1999-03-01","ids":{"openalex":"https://openalex.org/W2051297618","doi":"https://doi.org/10.1002/(sici)1097-0142(19990301)85:5<1091::aid-cncr12>3.0.co;2-a","mag":"2051297618","pmid":"https://pubmed.ncbi.nlm.nih.gov/10091793"},"language":"en","primary_location":{"id":"doi:10.1002/(sici)1097-0142(19990301)85:5<1091::aid-cncr12>3.0.co;2-a","doi":"https://doi.org/10.1002/(sici)1097-0142(19990301)85:5<1091::aid-cncr12>3.0.co;2-a","is_oa":false,"landing_page_url":"https://doi.org/10.1002/(sici)1097-0142(19990301)85:5<1091::aid-cncr12>3.0.co;2-a","pdf_url":null,"source":{"id":"https://openalex.org/S126033908","display_name":"Cancer","issn_l":"0008-543X","issn":["0008-543X","1045-7410","1097-0142"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2051297618"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/%28SICI%291097-0142%2819990301%2985%3A5%3C1091%3A%3AAID-CNCR12%3E3.0.CO%3B2-A","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5024942208","display_name":"C. Blajman","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Cesar Blajman","raw_affiliation_strings":["Argentina Oncology Group, Buenos Aires, Argentina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Argentina Oncology Group, Buenos Aires, Argentina","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111756123","display_name":"L. Balbiani","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L. Balbiani","raw_affiliation_strings":["Argentina Oncology Group, Buenos Aires, Argentina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Argentina Oncology Group, Buenos Aires, Argentina","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"J. Block","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. Block","raw_affiliation_strings":["Argentina Oncology Group, Buenos Aires, Argentina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Argentina Oncology Group, Buenos Aires, Argentina","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079099672","display_name":"Federico C\u00f3ppola","orcid":"https://orcid.org/0000-0002-5660-2006","observed_orcids":["https://orcid.org/0000-0002-5660-2006"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"F. Coppola","raw_affiliation_strings":["Argentina Oncology Group, Buenos Aires, Argentina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Argentina Oncology Group, Buenos Aires, Argentina","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"R. Chacon","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R. Chacon","raw_affiliation_strings":["Argentina Oncology Group, Buenos Aires, Argentina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Argentina Oncology Group, Buenos Aires, Argentina","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060759473","display_name":"Luis Enrique Fein","orcid":"https://orcid.org/0000-0003-2627-1346","observed_orcids":["https://orcid.org/0000-0003-2627-1346"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L. Fein","raw_affiliation_strings":["Argentina Oncology Group, Buenos Aires, Argentina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Argentina Oncology Group, Buenos Aires, Argentina","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069642159","display_name":"S. Bonicatto","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S. Bonicatto","raw_affiliation_strings":["Argentina Oncology Group, Buenos Aires, Argentina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Argentina Oncology Group, Buenos Aires, Argentina","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073693805","display_name":"Angeles A. Alvarez","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. Alvarez","raw_affiliation_strings":["Argentina Oncology Group, Buenos Aires, Argentina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Argentina Oncology Group, Buenos Aires, Argentina","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045670657","display_name":"Andres J. Schmilovich","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. Schmilovich","raw_affiliation_strings":["Argentina Oncology Group, Buenos Aires, Argentina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Argentina Oncology Group, Buenos Aires, Argentina","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5108573604","display_name":"Fran\u00e7ois-Michel Delgado","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405271382","display_name":"Institut de Recherche Pierre Fabre (France)","ror":"https://ror.org/02by0jk38","country_code":"FR","type":"company","lineage":["https://openalex.org/I4405271382"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"F. M. Delgado","raw_affiliation_strings":["Institut de Recherche Pierre Fabre-45, Boulogne, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut de Recherche Pierre Fabre-45, Boulogne, France","institution_ids":["https://openalex.org/I4405271382"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5024942208"],"corresponding_institution_ids":[],"apc_list":{"value":4790,"currency":"USD","value_usd":4790},"apc_paid":null,"fwci":2.3914,"has_fulltext":false,"cited_by_count":59,"citation_normalized_percentile":{"value":0.89176755,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"85","issue":"5","first_page":"1091","last_page":"1097"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.9473000168800354,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.9473000168800354,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.048700001090765,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10696","display_name":"Gastric Cancer Management and Outcomes","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/advanced-breast-cancer","display_name":"advanced breast cancer","score":0.9179999828338623},{"id":"https://openalex.org/keywords/metastatic-breast-cancer","display_name":"metastatic breast cancer","score":0.9459999799728394},{"id":"https://openalex.org/keywords/breast-cancer-recurrence","display_name":"breast cancer recurrence","score":0.8510000109672546},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.7760000228881836},{"id":"https://openalex.org/keywords/vinorelbine","display_name":"vinorelbine","score":0.7860000133514404},{"id":"https://openalex.org/keywords/doxorubicin","display_name":"doxorubicin","score":0.9679999947547913},{"id":"https://openalex.org/keywords/overall-response-rate","display_name":"overall response rate","score":0.8019999861717224},{"id":"https://openalex.org/keywords/survival","display_name":"survival","score":0.8980000019073486},{"id":"https://openalex.org/keywords/liver-metastases","display_name":"liver metastasis","score":0.8619999885559082},{"id":"https://openalex.org/keywords/cardiotoxicity","display_name":"cardiotoxicity","score":0.7229999899864197},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.968999981880188},{"id":"https://openalex.org/keywords/chemotherapy-toxicity","display_name":"chemotherapy toxicity","score":0.7699999809265137}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9357654452323914},{"id":"https://openalex.org/C2780456651","wikidata":"https://www.wikidata.org/wiki/Q238512","display_name":"Fluorouracil","level":3,"score":0.6427261829376221},{"id":"https://openalex.org/C2780350996","wikidata":"https://www.wikidata.org/wiki/Q420532","display_name":"Vinorelbine","level":4,"score":0.6312804818153381},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6311094760894775},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5524807572364807},{"id":"https://openalex.org/C2781303535","wikidata":"https://www.wikidata.org/wiki/Q18936","display_name":"Doxorubicin","level":3,"score":0.5514102578163147},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5277101397514343},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.5010678768157959},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.49678829312324524},{"id":"https://openalex.org/C2778233292","wikidata":"https://www.wikidata.org/wiki/Q2118956","display_name":"Cardiotoxicity","level":3,"score":0.4604736864566803},{"id":"https://openalex.org/C31760486","wikidata":"https://www.wikidata.org/wiki/Q7180990","display_name":"Phases of clinical research","level":3,"score":0.4485102593898773},{"id":"https://openalex.org/C188816634","wikidata":"https://www.wikidata.org/wiki/Q2113324","display_name":"Prospective cohort study","level":2,"score":0.41413068771362305},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.4070689082145691},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.057114601135253906}],"mesh":[{"descriptor_ui":"D000077235","descriptor_name":"Vinorelbine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000972","descriptor_name":"Antineoplastic Agents, Phytogenic","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D003520","descriptor_name":"Cyclophosphamide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005472","descriptor_name":"Fluorouracil","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009364","descriptor_name":"Neoplasm Recurrence, Local","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014747","descriptor_name":"Vinblastine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014747","descriptor_name":"Vinblastine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D016019","descriptor_name":"Survival Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018450","descriptor_name":"Disease Progression","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018572","descriptor_name":"Disease-Free Survival","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1002/(sici)1097-0142(19990301)85:5<1091::aid-cncr12>3.0.co;2-a","doi":"https://doi.org/10.1002/(sici)1097-0142(19990301)85:5<1091::aid-cncr12>3.0.co;2-a","is_oa":false,"landing_page_url":"https://doi.org/10.1002/(sici)1097-0142(19990301)85:5<1091::aid-cncr12>3.0.co;2-a","pdf_url":null,"source":{"id":"https://openalex.org/S126033908","display_name":"Cancer","issn_l":"0008-543X","issn":["0008-543X","1045-7410","1097-0142"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer","raw_type":"journal-article"},{"id":"doi:10.1002/(sici)1097-0142(19990301)85:5<1091::aid-cncr12>3.3.co;2-1","doi":"https://doi.org/10.1002/(sici)1097-0142(19990301)85:5<1091::aid-cncr12>3.3.co;2-1","is_oa":true,"landing_page_url":"https://doi.org/10.1002/(sici)1097-0142(19990301)85:5<1091::aid-cncr12>3.3.co;2-1","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/%28SICI%291097-0142%2819990301%2985%3A5%3C1091%3A%3AAID-CNCR12%3E3.0.CO%3B2-A","source":{"id":"https://openalex.org/S126033908","display_name":"Cancer","issn_l":"0008-543X","issn":["0008-543X","1045-7410","1097-0142"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer","raw_type":"journal-article"},{"id":"pmid:10091793","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10091793","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer","raw_type":"Clinical Trial"}],"best_oa_location":{"id":"doi:10.1002/(sici)1097-0142(19990301)85:5<1091::aid-cncr12>3.3.co;2-1","doi":"https://doi.org/10.1002/(sici)1097-0142(19990301)85:5<1091::aid-cncr12>3.3.co;2-1","is_oa":true,"landing_page_url":"https://doi.org/10.1002/(sici)1097-0142(19990301)85:5<1091::aid-cncr12>3.3.co;2-1","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/%28SICI%291097-0142%2819990301%2985%3A5%3C1091%3A%3AAID-CNCR12%3E3.0.CO%3B2-A","source":{"id":"https://openalex.org/S126033908","display_name":"Cancer","issn_l":"0008-543X","issn":["0008-543X","1045-7410","1097-0142"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2051297618.pdf","grobid_xml":"https://content.openalex.org/works/W2051297618.grobid-xml"},"referenced_works_count":19,"referenced_works":["https://openalex.org/W12356482","https://openalex.org/W1843618725","https://openalex.org/W1918151945","https://openalex.org/W1973243411","https://openalex.org/W2004454292","https://openalex.org/W2018613526","https://openalex.org/W2021902088","https://openalex.org/W2054376929","https://openalex.org/W2066465524","https://openalex.org/W2137501619","https://openalex.org/W2167805334","https://openalex.org/W2176579253","https://openalex.org/W2212225357","https://openalex.org/W2271753451","https://openalex.org/W2285207413","https://openalex.org/W2293688022","https://openalex.org/W2339632762","https://openalex.org/W2409431091","https://openalex.org/W4244497714"],"related_works":["https://openalex.org/W4244497714","https://openalex.org/W2397030161","https://openalex.org/W12356482","https://openalex.org/W2024003853","https://openalex.org/W2131833143","https://openalex.org/W2417094306","https://openalex.org/W1923449517","https://openalex.org/W2119652522","https://openalex.org/W2331336292","https://openalex.org/W1991641981"],"abstract_inverted_index":{"BACKGROUND:":[0],"A":[1],"prospective,":[2],"multicenter,":[3],"randomized,":[4],"Phase":[5],"III":[6],"trial":[7],"comparing":[8],"the":[9,29,58,107,134,203,270],"efficacy":[10,231],"of":[11,23,31,86,145,156,160,169,197,202,212,226,232,248,274,283],"combination":[12,22,273],"chemotherapy":[13],"with":[14,20,33,76,84,149,166,187,208,250,265,279],"5-fluorouracil,":[15],"doxorubicin,":[16],"and":[17,25,42,78,90,110,133,176,218],"cyclophosphamide":[18],"(FAC)":[19],"a":[21,167,209,223,246,262],"vinorelbine":[24],"doxorubicin":[26],"(NA)":[27],"in":[28,147,158,199,245,261],"treatment":[30],"patients":[32,44,61,72,80,148,173,180,198,249],"advanced":[34],"breast":[35,53],"carcinoma":[36,54],"was":[37,125,138,152,185,206],"undertaken.":[38],"METHODS:":[39],"One":[40],"hundred":[41],"seventy-seven":[43],"who":[45,73,81],"previously":[46],"were":[47,55,74,82,104,111,164],"untreated":[48],"for":[49,106,123,136,172,179],"recurrent":[50],"or":[51],"metastatic":[52,252],"entered":[56],"into":[57],"study;":[59],"7":[60],"could":[62],"not":[63],"be":[64,242],"assessed.":[65],"The":[66,100,143,230],"final":[67],"analysis":[68],"relates":[69],"to":[70,116,214],"85":[71,79],"treated":[75,83],"FAC":[77,124,157,175,221],"NA,":[85],"whom":[87],"21":[88],"(25%)":[89],"44":[91],"(52%),":[92],"respectively,":[93],"had":[94],"received":[95],"prior":[96,114],"adjuvant":[97,117],"chemotherapy.":[98],"RESULTS:":[99],"overall":[101,119],"response":[102,120],"rates":[103],"similar":[105],"two":[108,234],"treatments":[109],"unaffected":[112],"by":[113],"exposure":[115],"therapy;":[118],"rate":[121],"(ORR)":[122],"74%":[126],"(95%":[127,140],"confidence":[128],"interval":[129],"[95%":[130],"CI],":[131],"65-83%),":[132],"ORR":[135],"NA":[137,146,205,240,275],"75%":[139],"CI,":[141],"66-84%).":[142],"activity":[144,278],"liver":[150,255],"involvement":[151],"greater":[153],"than":[154],"that":[155],"terms":[159],"survival.":[161],"Overall":[162],"survivals":[163],"similar,":[165,238],"median":[168],"17.3":[170],"months":[171,178],"receiving":[174,181],"17.8":[177],"NA.":[182],"Severe":[183],"toxicity":[184],"uncommon":[186],"World":[188],"Health":[189],"Organization":[190],"Grade":[191,284],"3-4":[192,285],"neutropenia":[193],"affecting":[194],"only":[195],"7%":[196],"each":[200],"arm":[201],"study.":[204],"associated":[207],"higher":[210],"incidence":[211],"mild":[213,227],"moderate":[215],"constipation,":[216],"neurotoxicity,":[217],"phlebitis,":[219],"whereas":[220],"produced":[222],"slight":[224],"excess":[225,282],"cardiotoxicity.":[228],"CONCLUSIONS:":[229],"these":[233],"regimens":[235],"is":[236,258],"very":[237],"although":[239],"may":[241],"more":[243],"active":[244],"subset":[247],"visceral":[251],"disease,":[253],"particularly":[254],"involvement.":[256],"It":[257],"clear":[259],"that,":[260],"direct":[263],"comparison":[264],"an":[266],"established":[267],"three-drug":[268],"regimen,":[269],"newer":[271],"two-drug":[272],"demonstrated":[276],"equivalent":[277],"no":[280],"significant":[281],"toxicity.":[286]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2051297618","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":3},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
